Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 1 Issue: 2, June

Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies

Volume:1   Issue: 2
Pp: 93-105
Chung-Pu Wu, Anna Maria Calcagno and Suresh V. Ambudkar
DOI: 10.2174/1874467210801020093
Published on: 01 March, 2012

Modulation of Transmitter Release Via Presynaptic Ligand-Gated Ion Channels open access plus

Volume:1   Issue: 2
Pp: 106-129
K. W. Schicker, M. M. Dorostkar and S. Boehm
DOI: 10.2174/1874467210801020106
Published on: 01 March, 2012

Emerging Therapeutic Strategies for Hepatitis C Virus Infection

Volume:1   Issue: 2
Pp: 130-150
Ken Sato, Hitoshi Takagi, Takeshi Ichikawa, Satoru Kakizaki and Masatomo Mori
DOI: 10.2174/1874467210801020130
Published on: 01 March, 2012

Diamidine Activity Against Trypanosomes: The State of the Art

Volume:1   Issue: 2
Pp: 151-161
M. N.C. Soeiro, S.L. de Castro, E.M de Souza, D. G.J. Batista, C. F. Silva and D. W. Boykin
DOI: 10.2174/1874467210801020151
Published on: 01 March, 2012

DNA Polymerases and Oxidative Damage: Friends or Foes?

Volume:1   Issue: 2
Pp: 162-170
A. Amoroso, E. Crespan, U. Wimmer, U. Hubscher and G. Maga
DOI: 10.2174/1874467210801020162
Published on: 01 March, 2012

Host Genetic Factors and Treatment of Hepatitis C

Volume:1   Issue: 2
Pp: 171-180
Jacob Nattermann, Ludger Leifeld and Ulrich Spengler
DOI: 10.2174/1874467210801020171
Published on: 01 March, 2012